Literature DB >> 18854849

Relationship between serum bilirubin and albuminuria in patients with type 2 diabetes.

Michiaki Fukui1, Muhei Tanaka, Emi Shiraishi, Ichiko Harusato, Hiroko Hosoda, Mai Asano, Goji Hasegawa, Naoto Nakamura.   

Abstract

Previous studies showed that low serum bilirubin concentrations are associated with increased risk of cardiovascular disease. To explore this further, we evaluated the relationships between serum bilirubin concentrations and the degree of urinary albumin excretion and other markers of subclinical atherosclerosis in 633 consecutive patients with type 2 diabetes. Multiple regression analysis showed that the serum bilirubin concentration was an independent determinant of and had a significant inverse correlation to the log urinary albumin excretion. Serum bilirubin concentrations were significantly lower in patients with than in those without cardiovascular disease. A significant inverse correlation was found between the serum bilirubin concentration and pulse wave velocity, while a significant positive correlation was found to the ankle-brachial index in a subgroup of 386 patients. Our study shows that the serum bilirubin level is associated with microalbuminuria and subclinical atherosclerosis in patients with type 2 diabetes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18854849     DOI: 10.1038/ki.2008.398

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  37 in total

1.  Inverse association between serum total bilirubin levels and diabetic peripheral neuropathy in patients with type 2 diabetes.

Authors:  Eun Sook Kim; Sung Won Lee; Eun Young Mo; Sung Dae Moon; Je Ho Han
Journal:  Endocrine       Date:  2015-04-07       Impact factor: 3.633

Review 2.  Haeme oxygenase signalling pathway: implications for cardiovascular disease.

Authors:  Laura E Fredenburgh; Allison A Merz; Susan Cheng
Journal:  Eur Heart J       Date:  2015-03-31       Impact factor: 29.983

Review 3.  Hyperbilirubinemia, Hypertension, and CKD: the Links.

Authors:  Ibrahim Mortada
Journal:  Curr Hypertens Rep       Date:  2017-07       Impact factor: 5.369

4.  Serum bilirubin levels are negatively associated with diabetic retinopathy in patients with type 1 diabetes and normal renal function.

Authors:  Tomislav Bulum; Martina Tomić; Lea Duvnjak
Journal:  Int Ophthalmol       Date:  2017-05-18       Impact factor: 2.031

5.  Bilirubin exerts pro-angiogenic property through Akt-eNOS-dependent pathway.

Authors:  Yasumasa Ikeda; Hirofumi Hamano; Akiho Satoh; Yuya Horinouchi; Yuki Izawa-Ishizawa; Yoshitaka Kihira; Keisuke Ishizawa; Ken-Ichi Aihara; Koichiro Tsuchiya; Toshiaki Tamaki
Journal:  Hypertens Res       Date:  2015-07-02       Impact factor: 3.872

6.  Renal function in diabetic nephropathy.

Authors:  Pradeep Kumar Dabla
Journal:  World J Diabetes       Date:  2010-05-15

7.  Prognostic impact of serum bilirubin level on long-term renal survival in IgA nephropathy.

Authors:  Shigeru Tanaka; Toshiharu Ninomiya; Kosuke Masutani; Masaharu Nagata; Akihiro Tsuchimoto; Kazuhiko Tsuruya; Takanari Kitazono
Journal:  Clin Exp Nephrol       Date:  2015-02-21       Impact factor: 2.801

8.  Bilirubin increases insulin sensitivity in leptin-receptor deficient and diet-induced obese mice through suppression of ER stress and chronic inflammation.

Authors:  Huansheng Dong; Hu Huang; Xinxu Yun; Do-sung Kim; Yinan Yue; Hongju Wu; Alton Sutter; Kenneth D Chavin; Leo E Otterbein; David B Adams; Young-Bum Kim; Hongjun Wang
Journal:  Endocrinology       Date:  2014-01-01       Impact factor: 4.736

9.  Serum Bilirubin and Their Association With C-Reactive Protein in Patients With Migraine.

Authors:  You-Fan Peng; Li-Qiu Xie; Yang Xiang; Gui-Dan Xu
Journal:  J Clin Lab Anal       Date:  2016-03-21       Impact factor: 2.352

10.  Higher serum total bilirubin concentration is associated with lower risk of renal insufficiency in an adult population.

Authors:  Ang-Tse Lee; Ya-Yu Wang; Shih-Yi Lin; Jiin-Tsae Liang; Wayne Huey-Herng Sheu; Yuh-Min Song; Wen-Dau Chang
Journal:  Int J Clin Exp Med       Date:  2015-10-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.